Sol Gel Technologies Ltd
F:4SG

Watchlist Manager
Sol Gel Technologies Ltd Logo
Sol Gel Technologies Ltd
F:4SG
Watchlist
Price: 46.8 EUR 6.36% Market Closed
Market Cap: 1.3B EUR

Relative Value

The Relative Value of one 4SG stock under the Base Case scenario is hidden EUR. Compared to the current market price of 46.8 EUR, Sol Gel Technologies Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

4SG Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
49
vs Industry
64
Median 3Y
6.2
Median 5Y
8.2
Industry
2.7
Forward
6.3
vs History
vs Industry
Median 3Y
-1.8
Median 5Y
-2
Industry
21.6
Forward
-83.5
vs History
vs Industry
Median 3Y
-3.3
Median 5Y
-8.4
Industry
16.9
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-8.3
Industry
22.9
vs History
4
vs Industry
76
Median 3Y
1.1
Median 5Y
2.3
Industry
2.3
vs History
34
vs Industry
86
Median 3Y
0.4
Median 5Y
3.3
Industry
3
Forward
5.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.6
vs History
vs Industry
52
Median 3Y
-0.1
Median 5Y
-0.2
Industry
13.4
vs History
vs Industry
50
Median 3Y
-0.1
Median 5Y
-0.2
Industry
16.7
Forward
-38.1
vs History
vs Industry
54
Median 3Y
-0.2
Median 5Y
-6.2
Industry
16.1
vs History
vs Industry
41
Median 3Y
-0.2
Median 5Y
-6.1
Industry
18.9
vs History
22
vs Industry
76
Median 3Y
0.8
Median 5Y
6.1
Industry
2

Multiples Across Competitors

4SG Competitors Multiples
Sol Gel Technologies Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IL
Sol Gel Technologies Ltd
F:4SG
161.6m EUR 8.5 -18 -14 -13.8
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.6 37.3 40
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
491.8B USD 5.4 19.7 16.1 20.9
CH
Roche Holding AG
SIX:ROG
271.4B CHF 4.4 28.8 12.3 14.3
UK
AstraZeneca PLC
LSE:AZN
220.4B GBP 5.1 31.4 108.7 159.2
US
Merck & Co Inc
NYSE:MRK
274.9B USD 4.3 14.5 10.3 12.2
CH
Novartis AG
SIX:NOVN
218.8B CHF 4.9 19.1 12.1 15.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.4 16.3 11.3 13.2
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.9B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
IL
Sol Gel Technologies Ltd
F:4SG
Average P/E: 25
Negative Multiple: -18
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55.6
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.7
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.8
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.4
37%
0.8
US
Merck & Co Inc
NYSE:MRK
14.5
15%
1
CH
Novartis AG
SIX:NOVN
19.1
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
16.3
3%
5.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IL
Sol Gel Technologies Ltd
F:4SG
Average EV/EBITDA: 440.1
Negative Multiple: -14
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37.3
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.1
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.3
5%
2.5
UK
AstraZeneca PLC
LSE:AZN
108.7
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
CH
Novartis AG
SIX:NOVN
12.1
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
1%
11.3
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IL
Sol Gel Technologies Ltd
F:4SG
Average EV/EBIT: 1 883.7
Negative Multiple: -13.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
40
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.9
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.3
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.2
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
CH
Novartis AG
SIX:NOVN
15.6
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5